Now Offering Endura-Kit™ Injectable For Postsurgical Non-Opioid Pain Management. Brought to you by InfuBLOCK™.
Endura-Kit™ features a patented local anesthetic compound, Enduracaine™, consisting of three non-opioid drugs: Tetracaine, Lidocaine and Epinephrine, to provide non-opioid pain control for enhanced recovery after surgery.
Endura-KitTM may be suitable for a variety of surgical procedures for longer-acting local incisional infiltration as well as for longer-acting regional anesthesia with peripheral nerve blocks and fascial plane blocks.
The low toxicity of this combination, due to the dilute concentration of the components, allows for higher volume dosing for volume/plane blocks to ensure full coverage of affected nerves.2,3
Pain-Control Applications: Use for incisional infiltration, major and minor regional nerve blocks, soft tissue infiltration, subcutaneous, epidural and intra-articular injection.
What is Endura-Kit™ Injectable? (Tetracaine 0.2%/Lidocaine 0.4%, Epinephrine 1:1000)
Endura-Kit™ is a local anesthesia compound that offers a solution for non-opioid pain relief. Endura-Kit™ provides long acting, safe pain relief for post-operative care.
Endura-Kit™ contains two components, which, when combined, mixes into a preservative-free, patented local anesthetic compound.
Endura-Kit™ consists of one preloaded Luer-Lock syringe with an 18g mixing needle containing 0.2mL of Epinephrine 1:1000, and one vial containing 50mL of Tetracaine and Lidocaine. Combining these two components results in a solution of 0.2% Tetracaine/0.4% Lidocaine with Epinephrine 1:250,000.
Disclaimer: Medications can only be ordered by health care providers when it is determined the product is clinically significant over other commercially available products. Endura-Kit™ is not recommended for obstetric, spinal topical or intravenous use. This product is an off-label use of two long available and very safe anesthetics. Endura-Kit™ has not been evaluated or approved by the FDA. Because Enduracaine™ is made from a combination of currently approved USP products, its use before specific FDA approval of a new drug application is safe and acceptable.
InfuSystem is a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers by delivering ambulatory pumps and supplies, along with related clinical, biomedical, and billing services to practices and patients nationwide. With a comprehensive suite of services, InfuSystem improves clinician access to quality medical equipment and promotes patient wellness and safety, while reducing the overall cost of infusion care.
InfuSystem offers Oncology, Pain Management and Negative Pressure Wound therapies. The company’s Durable Medical Equipment (DME) Services are comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair including onsite and depot services. InfuSystem provides the sale, rental, lease and associated supplies including infusion pumps, nerve blocks for acute pain, nerve block catheters, post-operative pain pumps, central venous catheters, IV pumps, pole-mounted pumps, syringe pumps, enteral pumps, Huber needles, clean room supplies, IV extension tubing, pump tubing, ambulatory pumps, replacement pumps, disposable products, central venous access devices, closed system transfer devices, negative pressure wound therapy vacs, wound vac, and chemotherapy and oncology infusion pumps. Biomedical services include both on-site and depot preventative maintenance, repair and warranty services, ranging from equipment inspections to extensive repairs including compression device systems, defibrillators, EKG machines, electrosurgical units, external pacemakers, humidifiers, infusion pumps, LCDs, light sources, modules, patient monitors, printers, pulse oximeters, telemetry transmitters, tourniquets – all completed to factory specifications.
Headquartered in Rochester Hills, Michigan, InfuSystem delivers local, field-based customer support and operates Centers of Excellence in Michigan, Kansas, California, Massachusetts, Texas and Ontario, Canada.